Review
doi: 10.1111/j.1526-4610.2005.4501006.x.
Molecular pharmacology of topiramate: managing seizures and preventing migraine
Affiliations
- PMID: 15833090
- DOI: 10.1111/j.1526-4610.2005.4501006.x
Item in Clipboard
Review
Molecular pharmacology of topiramate: managing seizures and preventing migraine
Headache.
2005 Apr.
Abstract
Topiramate is a neuromodulatory compound with stabilizing properties that was initially introduced for the management of partial seizures. Topiramate has been demonstrated to modify several receptor-gated and voltage-sensitive ion channels, including voltage-activated Na+ and Ca2+ channels and non-NMDA receptors. These receptors have been implicated in the pathophysiology of both epilepsy and migraine. The pharmacological mechanisms of action for topiramate that may explain its antiepileptic and migraine preventive activities will be discussed in this review. In addition, the potential relationship between the molecular activities of topiramate and its efficacy in epilepsy and migraine prevention will be emphasized.
Similar articles
-
Clinical pharmacology of topiramate in migraine prevention.Expert Opin Drug Metab Toxicol. 2011 Sep;7(9):1169-81. doi: 10.1517/17425255.2011.602067. Epub 2011 Jul 15. Expert Opin Drug Metab Toxicol. 2011. PMID: 21756204 Review.
-
Topiramate monotherapy in epilepsy and migraine prevention.Clin Ther. 2005 Feb;27(2):154-65. doi: 10.1016/j.clinthera.2005.02.013. Clin Ther. 2005. PMID: 15811478 Review.
-
Practical use of topiramate for migraine prevention.Headache. 2005 Apr;45 Suppl 1:S66-73. doi: 10.1111/j.1526-4610.2005.4501007.x. Headache. 2005. PMID: 15833092 Review.
-
Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms.Trends Pharmacol Sci. 2007 Apr;28(4):188-95. doi: 10.1016/j.tips.2007.02.005. Epub 2007 Mar 6. Trends Pharmacol Sci. 2007. PMID: 17337068 Review.
-
Topiramate in migraine prevention.Headache. 2005 Apr;45 Suppl 1:S57-65. doi: 10.1111/j.1526-4610.2005.4501005.x. Headache. 2005. PMID: 15833091 Review.
Cited by
-
The α6 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation.Neuropharmacology. 2018 Sep 15;140:1-13. doi: 10.1016/j.neuropharm.2018.07.017. Epub 2018 Jul 21. Neuropharmacology. 2018. PMID: 30016665 Free PMC article.
-
Involvement of group II metabotropic glutamate receptors in stress-induced behavioural sensitization.Psychopharmacology (Berl). 2007 Apr;191(2):365-75. doi: 10.1007/s00213-006-0659-x. Epub 2007 Jan 16. Psychopharmacology (Berl). 2007. PMID: 17225168
-
Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.J Diabetes Sci Technol. 2011 May 1;5(3):714-22. doi: 10.1177/193229681100500326. J Diabetes Sci Technol. 2011. PMID: 21722587 Free PMC article. Clinical Trial.
-
Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis.Sci Rep. 2021 Mar 8;11(1):5402. doi: 10.1038/s41598-021-84751-3. Sci Rep. 2021. PMID: 33686135 Free PMC article.
-
Prophylactic treatment of migraine with topamax: long-term results.Neurosci Behav Physiol. 2007 Feb;37(2):125-7. doi: 10.1007/s11055-007-0159-4. Neurosci Behav Physiol. 2007. PMID: 17187203 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
